Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Vaccines, Blood & Biologics

2000 Biological New Drug Application (NDA) Approvals

This list reflects information regarding the application as of the approval date; it is not updated with regard to applicant or application status changes.


Tradename/
Established Name
Indication for Use Applicant Approval Date
None
Anticoagulant Sodium Citrate 4% w/v Solution, USP
Use only with automated apheresis devices in the collection of human plasma or in performing therapeutic plasma exchange procedures Haemonetics Corp
400 Wood Road
Braintree, MA 02184
3/3/2000

Page Last Updated: 04/09/2013
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.